The binding of PD-1 to its ligands programmed death ligands 1 and 2 (PD-L1 and PD-L2) found on cancer cells delivers inhibitory signals for T-cell activation, suppressing an immune response[35,36]. The gene discussed is CD274; the disease is cancer.